Howard R. Weeks

Howard R. Weeks, MD, MBA

Languages spoken: English

Academic Information

Departments Adjunct - Anesthesiology , Adjunct - Psychiatry

Divisions: Child & Adolescent Psychiatry

Board Certification

  • American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry)
  • American Board of Psychiatry & Neurology (Psychiatry)
  • American Board of Preventive Medicine (Clinical Informatics)

Howard Weeks, MD, MBA, Adjunct Professor, graduated from the "Triple Board" Program here at the University of Utah. He is trained in child & adolescent psychiatry, adult psychiatry and pediatrics as well as clinical informatics.

As clinical track faculty from 2002 until 2021, he was active in many of the clinical services at the former University Neuropsychiatric Institute, now Huntsman Mental Health Institute, including Medical Director of Youth Services and the Division Chief of Child & Adolescent Psychiatry, the Assistant Medical Director of ECT/TMS Services and the Medical Director of the Comprehensive Assessment and Treatment Program. He served as the Chief Medical Director at University of Utah Health Plans and was former Associate Chief and Interim Chief Medical Information Officer for University Health. As Associate Chief Medical Information Officer, he focused on improvement in clinical documentation thru the Epic EMR.

He is active in the community and served as the President of the Utah Psychiatric Association. He has been honored with the designation of “Distinguished Fellow of the American Psychiatric Association” by his colleagues. He is the current President Elect of the Utah Medical Association. Dr. Weeks has a strong interest in educating medical students, residents and attendings about personal finances and the impact that has on career choices. He actively lectures to a variety of groups on these topics.

Education History

Undergraduate North Carolina State
 BS
Internship Centers for Disease Control
 Research Intern
Professional Medical Duke University
 MD
Research Fellow Centers for Disease Control
 Research Fellow
Residency University of Utah School of Medicine
 Resident
Chief Resident University of Utah School of Medicine
 Chief Resident
Other Training University of Utah, David Eccles School of Business
Other Training Harvard Business School
Graduate Training University of Utah
 Graduate Certificate
Graduate Training Haslam College of Business, University of Tennessee Knoxville
 MBA

Selected Publications

Journal Article

  1. Wachtel LE, Dhossche DM, Fink M, Jaffe R, Kellner CH, Weeks H, Shorter E (2013). ECT for developmental disability and severe mental illness. Am J Psychiatry, 170(12), 1498-9. (Read full article)
  2. Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, Gwinn M (2002). Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health, 92(3), 385-7. (Read full article)
  3. Pierson MD, Mickey BJ, Gilley LB, Weeks HR II (2021). Outcomes of Youth Treated With Electroconvulsive Therapy: A Retrospective Cohort Study. The Journal of clinical psychiatry, 82(2), (Read full article)
  4. Murrill CS, Kuncl KA, Weeks HR, Whyte BM, Petersen LR, Janssen R (1992). HIV seroprevalence in hospital patients in rural Georgia. Southern medical journal, 85(10), 969-71. (Read full article)
  5. Weeks H (2015). Where Is the "Top of License" for the Psychiatrist?. The journal of ECT, 31(4), 209-10. (Read full article)
  6. Mickey BJ, White AT, Arp AM, Leonardi K, Torres MM, Larson AL, Odell DH, Whittingham SA, Beck MM, Jessop JE, Sakata DJ, Bushnell LA, Pierson MD, Solzbacher D, Kendrick EJ, Weeks HR 3rd, Light AR, Light KC, Tadler S (2018). Propofol for Treatment-Resistant Depression: A Pilot Study. The international journal of neuropsychopharmacology, 21(12), 1079-1089. (Read full article)
  7. Kukhareva P, Staes C, Noonan KW, Mueller HL, Warner P, Shields DE, Weeks H, Kawamoto (2017). Single-reviewer electronic phenotyping validation in operational settings: Comparison of strategies and recommendations. Journal of biomedical informatics, 66, 1-10. (Read full article)
  8. Iacob E, Light KC, Tadler SC, Weeks HR, White AT, Hughen RW, Vanhaitsma TA, Bushnell L, Light A (2013). Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls. BMC psychiatry, 13, 273. (Read full article)
  9. Unni P, Staes C, Weeks H, Kramer H, Borbolla D, Slager S, Taft T, Chidambaram V, Weir (2016). Why aren't they happy? An analysis of end-user satisfaction with Electronic health records. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2016, 2026-2035. (Read full article)
  10. Frech TM, Hess R, Biber J, Young J, Hardman A, Weeks H, Peterson KA, Scholand M (2018). Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care?LID - 10.1097/RHU.0000000000000715 [doi]. Journal of clinical rheumatology, 24(5), 272-274. (Read full article)
  11. Weeks HR 3rd, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, Landvatter JD, Chelune GJ, Suchy Y, Clark E, Cahalan MK, Bushnell L, Sakata D, Light AR, Light K (2013). Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression. PloS one, 8(7), e69809. (Read full article)
  12. Iacob E, Tadler SC, Light KC, Weeks HR, Smith KW, White AT, Hughen RW, VanHaitsma TA, Bushnell LA, Light A (2014). Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study. Depression research and treatment, 2014, 582380. (Read full article)
  13. Lopez-Larson MP, Shah LM, Weeks HR, King JB, Mallik AK, Yurgelun-Todd DA, Anderson J (2017). Abnormal Functional Connectivity Between Default and Salience Networks in Pediatric Bipolar Disorder. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2(1), 85-93. (Read full article)
  14. Weeks HR 3rd, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, Landvatter JD, Chelune GJ, Suchy Y, Clark E, Cahalan MK, Bushnell L, Sakata D, Light AR, Light K (2017). Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PloS one, 12(4), e0175668. (Read full article)
  15. Wassenaar E, Blalock DV, Duffy A, Riddle M, Weeks H, Mehler P, Rienecke R (2025). Is ketamine safe for individuals in higher level of care treatment for eating disorders? Analysis of safety of subanesthetic ketamine in 104 patients. Journal of psychiatric research, 188, 52-56. (Read full article)
  16. Biber J, Ose D, Reese J, Gardiner A, Facelli J, Spuhl J, Brodke D, Lee VS, Hess R, Weeks (2018). Patient reported outcomes - experiences with implementation in a University Health Care setting. Journal of patient-reported outcomes, 2, 34. (Read full article)

Case Report

  1. Kalani MY, Weeks H, Carlson E, Couldwell W (2017). Intraparenchymal hemorrhage after electroconvulsive therapy. Interdisciplinary neurosurgery, 9(9), 89-91.

Abstract

  1. Weeks HR, Hess R, Biber J, Reese J (Oct 2017). Maternal mental health and Patient Reported Outcomes: Identifying at risk pregnant and postpartnum patients [Abstract]. Qual Life Res, 26(1), 122.
  2. Biber, J, Hess, R, Weeks H, Reese, J (Oct 2017). Comparing automated mental health screeing to manual prcesses in a health care system [Abstract]. Qual Life Res, 26(1), 28.
  3. Biber J, Hess R, Weeks H (Oct 2017). Reviewing mental health in oncology: Measuring Mental Health Risks in Oncology through Patient Reported Outcomes [Abstract]. Qual Life Res, 26(1), 27.
  4. Biber J, Hess R, Weeks H, Reese J (Oct 2017). Comparing Mental Health to Physical Functioning [Abstract]. Qual Life Res, 26(1), 109.
  5. Tadler, Scott, Weeks, Howar (2011). "Isoflurane Treatment of Depression".
  6. Beresford, Weeks, Smith, Bushnell, Pac (2011). Risk Factors for the Number of ECT Treatments.
  7. Howard Weeks, Mikala Saccoman, et a (2011). An Investigation of the Effectiveness and Cognitive Side Effects of Bifrontal ECT.
  8. Laura Gilley-Hensley, M.D., Lowry, A. Bushnell, M.D., Kelly, W. Smith, M.D., Howard R. Weeks, M.D (2010). The Use of Electroconvulsive Therapy in Children and Adolescents at a Large Academic Center.
  9. Olsen J , Weeks H, Bushnell L, Smith (2010). Incidence of Headache, Nausea and Myalgia after ECT in Adolescents and Adults: Relation to Treatment Number and Patient Age.
  10. E. IACOB, S. C. TADLER, A. R. LIGHT, H. R. WEEKS, R. W. HUGHEN, K. W. SMITH, A. T. WHITE, L. BUSHNELL, K. C. LIGH (2011). Gene expression biomarkers for Major Depressive Disorder before and after ECT treatment. JJ17(10), 369.
  11. SC Tadler, HR Weeks, KW Smith, L. Bushnell, E. Iacob, AR Light, MK Cahalan, KC Ligh (2012). Antidepressant and neurocognitive effects of isoflurane versus ECT in medication resistant patients.
  12. Weeks, Smith, Bushnel (2012). Safety of Electroconvulsive Therapy in a Large Academic Practice over 12 years. 28(2), 144-150.
  13. Wilson, Tingey, Marchant, Smith, Bushnell, Week (2012). Comparision of aminophylline and caffeine augmentation in electroconvulsive therapy. 28(2), 144-150.
  14. Weeks, Smith, Tadler, Iacobs, Saccoman, Bushnell, Ligh (2012). Effectiveness and Cognitiave Side Effects of Isoflurane Relative to Electroconvulsive Therapy in the Treatment of Severe Depression. 28(2), 144-150.
  15. Tadler SC, White A, Arp A, Torres MM, Weeks H, Anderson C, Beck M, Bushnell L, Cahalan M, Hensley LG, Jessop J,Kendrick J, Larson A, Odell D, Pace N, Pierson M, Sakata D, Smith K, Whittingham S, Light K, Light A, Mickey B (2017). Antidepressant Effects of Propofol-Induced Burst Suppression.
  16. L. McMurtrey, BSN, RN, D. Knitz, ACNP-C, C. Webb, PA-C, K. Barger, MSW, H. Weeks, MD, A. Cochran, MD, FAC (2018). Implementation of Patient Reported Outcomes in a Burn Outpatient Clinic.
  17. Biber J, Hess R, Weeks H, Reese (2016). Implementing Patient Reported Outcomes (PROs) Throughout a Healthcare System.
  18. Biber J, Hess R, Weeks H, Reese (2016). Implementing Patient Reported Outcomes (PROs) Throughout a Healthcare System.
  19. Biber J, Hess R, Weeks H, Reese (2016). Implementing Patient Reported Outcomes (PROs) Throughout a Healthcare System.
  20. Weeks H, Biber J, Hess (2016). Reviewing Mental Health In Oncology Patients.
  21. Biber J, Hess R, Weeks H, Reese (2017). Implementing Patient Reported Outcomes (PROs) for Mental Health Screening throughout a Healthcare System.
  22. Mooney K, Biber J, Hess R, Weeks H, Sweetenham (2017). Implementing Routine Assessment of Patient Reported Outcomes in Cancer Care Background.
  23. Biber J, Hess R, Weeks (2017). Measuring Mental Health Risks in Oncology through Patient Reported Outcomes.
  24. Biber J, Gale C, Thackeray A, Cozart H, Weeks H, Hess (2018). Measuring Physical Ability and Functional Status through Patient Reported Outcomes (PROs).

Newspaper

  1. Weeks (2018). Op-Ed: More to do in Utah's mental health crisis.
  2. Jennifer Graha (2017). Why depression recovery rarely happens with a single solution.

Other

  1. O'Melia A, Ashworth J, Weeks H, Baese (2004). SSRI Use for the Treatment of Depression in the Pediatric Population. 2,